**Core Concept**
The IY1MR vaccine is a live attenuated vaccine used for the prevention of measles, mumps, and rubella (MMR) infections. It works by inducing a cellular and humoral immune response against the respective viruses.

**Why the Correct Answer is Right**
The IY1MR vaccine contains weakened forms of the measles, mumps, and rubella viruses, which stimulate the body's immune system to produce antibodies and immune cells that can recognize and eliminate these pathogens. This vaccine is particularly effective in preventing complications associated with these viral infections, such as encephalitis and deafness.

**Why Each Wrong Option is Incorrect**
**Option A:** This option is incorrect because the IY1MR vaccine is not a subunit vaccine, which would involve using only specific components of the virus, such as proteins or sugars, to stimulate an immune response.

**Option B:** This option is incorrect because the IY1MR vaccine is not a conjugate vaccine, which involves linking a weakened pathogen to a carrier protein to enhance immune response.

**Option C:** This option is incorrect because the IY1MR vaccine is not a toxoid vaccine, which involves inactivating bacterial toxins to prevent disease.

**Clinical Pearl / High-Yield Fact**
It is essential to note that the MMR vaccine is typically administered in two doses, with the first dose given at 12-15 months of age and the second dose at 4-6 years of age, to ensure long-term protection against these viral infections.

**Correct Answer: D. Live attenuated vaccine. Live attenuated vaccine.**